Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-020-02519-6.

Title:
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo | Cancer Immunology, Immunotherapy
Description:
Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC class I and adequate processing and presentation by malignant cells to trigger full activation of specific T cells. In silico prediction with three algorithms indicated 13 peptides of Cyclin A1 9 to 11 amino acids of length to have high affinity to HLA-A*02:01. Ten of them proved to be affine in an HLA stabilization assay using TAP-deficient T2 cells. Their immunogenicity was assessed by repetitive stimulation of CD8+ T cells from two healthy donors with single-peptide-pulsed dendritic cells or monocytes. Intracellular cytokine staining quantified the enrichment of peptide-specific functional T cells. Seven peptides were immunogenic, three of them against both donors. Specific cell lines were cloned and used in killing assays to demonstrate recognition of endogenous Cyclin A1 in the HLA-A*02:01-positive AML cell line THP-1. Immunopeptidome analysis based on direct isolation of HLA-presented peptides by mass spectrometry of primary AML and OC samples identified four naturally presented epitopes of Cyclin A1. The immunopeptidome of HeLa cells transfected with Cyclin A1 and HLA-A*02:01 revealed six Cyclin A1-derived HLA ligands. Epitope p410–420 showed high affinity to HLA-A*02:01 and immunogenicity in both donors. It proved to be naturally presented on primary AML blast and provoked spontaneous functional response of T cells from treatment naïve OC and, therefore, warrants further development for clinical application.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cell, cells, cyclin, article, pubmed, peptides, peptide, google, scholar, specific, cas, cancer, epitope, epitopes, hla, hlaa, target, central, analysis, antigen, affinity, mhc, presentation, lines, thp, tcr, vitro, therapy, stimulation, ligandome, immunotherapy, hlaarestricted, class, ctl, processing, data, leukemia, donors, selection, performed, control, fig, high, prediction, assay, immunogenicity, respective, pbmc, responses, presented,

Topics {✒️}

ny-eso-1-reactive t-cell receptor carboxyfluorescein-diacetat-succinimidyl-ester 10 µm cd4 rpa-t4-apc-h7 single-peptide-pulsed autologous derndritic cells gene-modified human t-cells article download pdf juliane sarah walz dimethyldodecylamineoxide-succinimidyl-ester 5 µm peptide-pulsed plastic-adherent fraction ratio}}_{{{\mathrm{effector}}}} }}{{{\mathrm{ full size image endogenous immunoglobulin-derived neoepitopes single-peptide-pulsed dendritic cells pd-1/pd-l1 blockade immunotherapy single-peptide-pulsed autologous cells high-grade ovarian cancer mart-1-peptide elagigiltv served individual peptide side-chains hla-a2-restricted hepatitis cyclin a1-derived hla identify cyclin a1-derived cyclin a1-derived peptides stained cd3 sk7-percp ratio}}_{{{\mathrm{norm}}}} }}} biochemical large-scale identification t-cell-based immunotherapy tnfα mab11-pe-cy7 acute myeloid leukemia 1 μg/ml β2-microglobulin peptide-specific lytic activity web server issue immatics biotechnologies gmbh high-affinity taa-specific tcr cytokine-naïve thp-1 cells flow cytometry-based assay translational scientists working showing specific killing alphabeta tcr-mediated recognition specifically lysed apc acquired funding original online version tap-deficient t2 cells peptide-pulsed t2 cells german cancer consortium cytokine-positive cd8+ lymphocytes treatment-naïve oc patients cancer testis antigen cancer-testis antigen acute lymphoblastic leukemia full access

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
         description:Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC class I and adequate processing and presentation by malignant cells to trigger full activation of specific T cells. In silico prediction with three algorithms indicated 13 peptides of Cyclin A1 9 to 11 amino acids of length to have high affinity to HLA-A*02:01. Ten of them proved to be affine in an HLA stabilization assay using TAP-deficient T2 cells. Their immunogenicity was assessed by repetitive stimulation of CD8+ T cells from two healthy donors with single-peptide-pulsed dendritic cells or monocytes. Intracellular cytokine staining quantified the enrichment of peptide-specific functional T cells. Seven peptides were immunogenic, three of them against both donors. Specific cell lines were cloned and used in killing assays to demonstrate recognition of endogenous Cyclin A1 in the HLA-A*02:01-positive AML cell line THP-1. Immunopeptidome analysis based on direct isolation of HLA-presented peptides by mass spectrometry of primary AML and OC samples identified four naturally presented epitopes of Cyclin A1. The immunopeptidome of HeLa cells transfected with Cyclin A1 and HLA-A*02:01 revealed six Cyclin A1-derived HLA ligands. Epitope p410–420 showed high affinity to HLA-A*02:01 and immunogenicity in both donors. It proved to be naturally presented on primary AML blast and provoked spontaneous functional response of T cells from treatment naïve OC and, therefore, warrants further development for clinical application.
         datePublished:2020-03-10T00:00:00Z
         dateModified:2021-06-25T00:00:00Z
         pageStart:1217
         pageEnd:1227
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00262-020-02519-6
         keywords:
            Cyclin A1
            Epitope
            CD8 T cell
            HLA immunopeptidome
            Acute myeloid leukemia
            Ovarian carcinoma
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig3_HTML.png
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:69
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Anja Tatjana Teck
               url:http://orcid.org/0000-0002-9563-0341
               affiliation:
                     name:Charité Berlin
                     address:
                        name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sabrina Urban
               affiliation:
                     name:Charité Berlin
                     address:
                        name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Petra Quass
               affiliation:
                     name:Charité Berlin
                     address:
                        name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:Charité Comprehensive Cancer Center
                     address:
                        name:Charité Comprehensive Cancer Center, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Annika Nelde
               affiliation:
                     name:University of Tübingen
                     address:
                        name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:University Hospital Tübingen
                     address:
                        name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heiko Schuster
               affiliation:
                     name:University of Tübingen
                     address:
                        name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:Immatics Biotechnologies GmbH
                     address:
                        name:Immatics Biotechnologies GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anne Letsch
               affiliation:
                     name:Charité Berlin
                     address:
                        name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Antonia Busse
               affiliation:
                     name:Charité Berlin
                     address:
                        name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Juliane Sarah Walz
               affiliation:
                     name:University of Tübingen
                     address:
                        name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ulrich Keilholz
               affiliation:
                     name:Charité Comprehensive Cancer Center
                     address:
                        name:Charité Comprehensive Cancer Center, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sebastian Ochsenreither
               affiliation:
                     name:Charité Berlin
                     address:
                        name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:Charité Comprehensive Cancer Center
                     address:
                        name:Charité Comprehensive Cancer Center, Berlin, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
      description:Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC class I and adequate processing and presentation by malignant cells to trigger full activation of specific T cells. In silico prediction with three algorithms indicated 13 peptides of Cyclin A1 9 to 11 amino acids of length to have high affinity to HLA-A*02:01. Ten of them proved to be affine in an HLA stabilization assay using TAP-deficient T2 cells. Their immunogenicity was assessed by repetitive stimulation of CD8+ T cells from two healthy donors with single-peptide-pulsed dendritic cells or monocytes. Intracellular cytokine staining quantified the enrichment of peptide-specific functional T cells. Seven peptides were immunogenic, three of them against both donors. Specific cell lines were cloned and used in killing assays to demonstrate recognition of endogenous Cyclin A1 in the HLA-A*02:01-positive AML cell line THP-1. Immunopeptidome analysis based on direct isolation of HLA-presented peptides by mass spectrometry of primary AML and OC samples identified four naturally presented epitopes of Cyclin A1. The immunopeptidome of HeLa cells transfected with Cyclin A1 and HLA-A*02:01 revealed six Cyclin A1-derived HLA ligands. Epitope p410–420 showed high affinity to HLA-A*02:01 and immunogenicity in both donors. It proved to be naturally presented on primary AML blast and provoked spontaneous functional response of T cells from treatment naïve OC and, therefore, warrants further development for clinical application.
      datePublished:2020-03-10T00:00:00Z
      dateModified:2021-06-25T00:00:00Z
      pageStart:1217
      pageEnd:1227
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00262-020-02519-6
      keywords:
         Cyclin A1
         Epitope
         CD8 T cell
         HLA immunopeptidome
         Acute myeloid leukemia
         Ovarian carcinoma
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig3_HTML.png
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:69
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Anja Tatjana Teck
            url:http://orcid.org/0000-0002-9563-0341
            affiliation:
                  name:Charité Berlin
                  address:
                     name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sabrina Urban
            affiliation:
                  name:Charité Berlin
                  address:
                     name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Petra Quass
            affiliation:
                  name:Charité Berlin
                  address:
                     name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:Charité Comprehensive Cancer Center
                  address:
                     name:Charité Comprehensive Cancer Center, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Annika Nelde
            affiliation:
                  name:University of Tübingen
                  address:
                     name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:University Hospital Tübingen
                  address:
                     name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heiko Schuster
            affiliation:
                  name:University of Tübingen
                  address:
                     name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:Immatics Biotechnologies GmbH
                  address:
                     name:Immatics Biotechnologies GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anne Letsch
            affiliation:
                  name:Charité Berlin
                  address:
                     name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Antonia Busse
            affiliation:
                  name:Charité Berlin
                  address:
                     name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Juliane Sarah Walz
            affiliation:
                  name:University of Tübingen
                  address:
                     name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ulrich Keilholz
            affiliation:
                  name:Charité Comprehensive Cancer Center
                  address:
                     name:Charité Comprehensive Cancer Center, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sebastian Ochsenreither
            affiliation:
                  name:Charité Berlin
                  address:
                     name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:Charité Comprehensive Cancer Center
                  address:
                     name:Charité Comprehensive Cancer Center, Berlin, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:69
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Charité Berlin
      address:
         name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
         type:PostalAddress
      name:Charité Berlin
      address:
         name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
         type:PostalAddress
      name:Charité Berlin
      address:
         name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
         type:PostalAddress
      name:Charité Comprehensive Cancer Center
      address:
         name:Charité Comprehensive Cancer Center, Berlin, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:University of Tübingen
      address:
         name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
         type:PostalAddress
      name:University Hospital Tübingen
      address:
         name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
         type:PostalAddress
      name:University of Tübingen
      address:
         name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
         type:PostalAddress
      name:Immatics Biotechnologies GmbH
      address:
         name:Immatics Biotechnologies GmbH, Tübingen, Germany
         type:PostalAddress
      name:Charité Berlin
      address:
         name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:Charité Berlin
      address:
         name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:University of Tübingen
      address:
         name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:Charité Comprehensive Cancer Center
      address:
         name:Charité Comprehensive Cancer Center, Berlin, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:Charité Berlin
      address:
         name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
         type:PostalAddress
      name:Charité Comprehensive Cancer Center
      address:
         name:Charité Comprehensive Cancer Center, Berlin, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Anja Tatjana Teck
      url:http://orcid.org/0000-0002-9563-0341
      affiliation:
            name:Charité Berlin
            address:
               name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Sabrina Urban
      affiliation:
            name:Charité Berlin
            address:
               name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Petra Quass
      affiliation:
            name:Charité Berlin
            address:
               name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:Charité Comprehensive Cancer Center
            address:
               name:Charité Comprehensive Cancer Center, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Annika Nelde
      affiliation:
            name:University of Tübingen
            address:
               name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:University Hospital Tübingen
            address:
               name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Heiko Schuster
      affiliation:
            name:University of Tübingen
            address:
               name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:Immatics Biotechnologies GmbH
            address:
               name:Immatics Biotechnologies GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Anne Letsch
      affiliation:
            name:Charité Berlin
            address:
               name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Antonia Busse
      affiliation:
            name:Charité Berlin
            address:
               name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Juliane Sarah Walz
      affiliation:
            name:University of Tübingen
            address:
               name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Ulrich Keilholz
      affiliation:
            name:Charité Comprehensive Cancer Center
            address:
               name:Charité Comprehensive Cancer Center, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Sebastian Ochsenreither
      affiliation:
            name:Charité Berlin
            address:
               name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:Charité Comprehensive Cancer Center
            address:
               name:Charité Comprehensive Cancer Center, Berlin, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
      name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
      name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
      name:Charité Comprehensive Cancer Center, Berlin, Germany
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
      name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
      name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
      name:Immatics Biotechnologies GmbH, Tübingen, Germany
      name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Charité Comprehensive Cancer Center, Berlin, Germany
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
      name:Charité Comprehensive Cancer Center, Berlin, Germany
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany

External Links {🔗}(194)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.23s.